Results
1 -
5 of
5
(Click
here to explore results)
- Histone deacetylase inhibitors for the treatment of cancer stem cells. M. Dvorakova, T. Vanek
, Med. Chem. Commun.
, 2016
, 7
, 2217
- Development of second generation epigenetic agents. Philip Jones
, Med. Chem. Commun.
, 2012
, 3
, 135
- Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1. Mingtao Ao, Zhenrui Pan, Yuqing Qian, Bowen Tang, Zeming Feng, Hua Fang, Zhen Wu, Jingwei Chen, Yuhua Xue, Meijuan Fang
, RSC Adv.
, 2018
, 8
, 17279
- Exploration of the medical periodic table: towards new targets. Nicolas P. E. Barry, Peter J. Sadler
, Chem. Commun.
, 2013
, 49
, 5106
- Developing novel non-hydroxamate histone deacetylase
inhibitors: the chelidamic warhead. Sergio Valente, Mariarosaria Conte, Maria Tardugno, Angela Nebbioso, Gabriella Tinari, Lucia Altucci, Antonello Mai
, Med. Chem. Commun.
, 2012
, 3
, 298